Jeena Sikho LifecareNSE:JSLL -1.22%92 EV-to-EBITDA is 19.29 as of Jul. 09, 2026, which is 52% below its 10-year median of 40.37. GuruFocus rates NSE:JSLL with a GF Score™ of 92/100 and a GF Value™ of ₹776.79 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks worse than 75.1% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Jeena Sikho Lifecare's enterprise value is ₹69,043 Mil.
Jeena Sikho Lifecare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,579 Mil. Therefore, Jeena Sikho Lifecare's EV-to-EBITDA for today is 19.29.
The historical rank and industry rank for Jeena Sikho Lifecare's EV-to-EBITDA or its related term are showing as below:
NSE:JSLL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 19.13 Med: 40.37 Max: 133.65
Current: 19.3
During the past 8 years, the highest EV-to-EBITDA of Jeena Sikho Lifecare was 133.65. The lowest was 19.13. And the median was 40.37.
NSE:JSLL's EV-to-EBITDA is ranked worse than 75.1% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 10.83
vs NSE:JSLL: 19.30
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jeena Sikho Lifecare's PE Ratio (TTM) for today is calculated as:
Jeena Sikho Lifecare's share price for today is ₹563.45.
Jeena Sikho Lifecare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17.810.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Jeena Sikho Lifecare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's EV-to-EBITDA falls into.
Jeena Sikho Lifecare's current Enterprise Value is ₹69,043 Mil.
Jeena Sikho Lifecare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,579 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeena Sikho Lifecare (NSE:JSLL) has a EV-to-EBITDA of 19.29 as of Jul. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Jeena Sikho Lifecare. This is 52% below median its historical median of 40.37. Over the past decade, Jeena Sikho Lifecare's EV-to-EBITDA has ranged from 19.13 to 133.65. According to the industry distribution chart, Jeena Sikho Lifecare ranks #380 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 75.1%.
Is Jeena Sikho Lifecare's EV-to-EBITDA too high?
Jeena Sikho Lifecare's current EV-to-EBITDA of 19.29 is 52% below median its 10-year median of 40.37. Over the past 10 years, this metric has ranged from a low of 19.13 to a high of 133.65. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.83. Jeena Sikho Lifecare's value of 19.29 is 78.1% above this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #380 out of 506 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #380 out of 506 companies for EV-to-EBITDA. This places Jeena Sikho Lifecare in the lower half of its industry. The industry median EV-to-EBITDA is 10.83. Jeena Sikho Lifecare's value of 19.29 is 78.1% above this benchmark. Historically, Jeena Sikho Lifecare's own EV-to-EBITDA has ranged from 19.13 to 133.65 over the past decade. While the company's 10-year median is 40.37 vs. the industry median of 10.83, Jeena Sikho Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.83, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current EV-to-EBITDA of 19.29 is 78.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Jeena Sikho Lifecare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current EV-to-EBITDA is 19.29, which is 52% below median its own 10-year median of 40.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹776.79, compared to a current price of ₹563.45 — trading 27.5% below its estimated fair value. The current EV-to-EBITDA is 19.29, which is 52% below median its 10-year median of 40.37 and 78.1% above the Healthcare Providers & Services industry median of 10.83. Jeena Sikho Lifecare's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current EV-to-EBITDA is 19.29 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹563.45 is trading 27.5% below its estimated GF Value™ of ₹776.79.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
EV-to-EBITDA: 19.29 (52% below median its 10-year median of 40.37)
GF Value™: ₹776.79 vs. price of ₹563.45 (27.5% below fair value)
Industry Position: 78.1% above the Healthcare Providers & Services median (#380 of 506)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
92GF Score
Get the complete analysis for NSE:JSLL
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
